229 related articles for article (PubMed ID: 8525613)
1. The vaccinia virus A38L gene product is a 33-kDa integral membrane glycoprotein.
Parkinson JE; Sanderson CM; Smith GL
Virology; 1995 Dec; 214(1):177-88. PubMed ID: 8525613
[TBL] [Abstract][Full Text] [Related]
2. Vaccinia virus gene B7R encodes an 18-kDa protein that is resident in the endoplasmic reticulum and affects virus virulence.
Price N; Tscharke DC; Hollinshead M; Smith GL
Virology; 2000 Feb; 267(1):65-79. PubMed ID: 10648184
[TBL] [Abstract][Full Text] [Related]
3. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
Parkinson JE; Smith GL
Virology; 1994 Oct; 204(1):376-90. PubMed ID: 8091668
[TBL] [Abstract][Full Text] [Related]
4. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
Engelstad M; Smith GL
Virology; 1993 Jun; 194(2):627-37. PubMed ID: 8503178
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the vaccinia virus A38L integral membrane protein promotes Ca2+ influx into infected cells.
Sanderson CM; Parkinson JE; Hollinshead M; Smith GL
J Virol; 1996 Feb; 70(2):905-14. PubMed ID: 8551630
[TBL] [Abstract][Full Text] [Related]
6. Identification of viral membrane proteins required for cell fusion and viral dissemination that are modified during vaccinia virus persistence.
Ortiz MA; Paez E
Virology; 1994 Jan; 198(1):155-68. PubMed ID: 8259650
[TBL] [Abstract][Full Text] [Related]
7. Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis.
Fischer SF; Ludwig H; Holzapfel J; Kvansakul M; Chen L; Huang DC; Sutter G; Knese M; Häcker G
Cell Death Differ; 2006 Jan; 13(1):109-18. PubMed ID: 16003387
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the vaccinia virus A35R protein and its role in virulence.
Roper RL
J Virol; 2006 Jan; 80(1):306-13. PubMed ID: 16352555
[TBL] [Abstract][Full Text] [Related]
9. The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles.
van Eijl H; Hollinshead M; Smith GL
Virology; 2000 May; 271(1):26-36. PubMed ID: 10814567
[TBL] [Abstract][Full Text] [Related]
10. The vaccinia virus A4OR gene product is a nonstructural, type II membrane glycoprotein that is expressed at the cell surface.
Wilcock D; Duncan SA; Traktman P; Zhang WH; Smith GL
J Gen Virol; 1999 Aug; 80 ( Pt 8)():2137-2148. PubMed ID: 10466813
[TBL] [Abstract][Full Text] [Related]
11. Intracellular processing of pseudorabies virus glycoprotein M (gM): gM of strain Bartha lacks N-glycosylation.
Dijkstra JM; Mettenleiter TC; Klupp BG
Virology; 1997 Oct; 237(1):113-22. PubMed ID: 9344913
[TBL] [Abstract][Full Text] [Related]
12. Cloning, characterization, and expression of the murine cytomegalovirus homologue of the human cytomegalovirus 28-kDa matrix phosphoprotein (UL99).
Cranmer LD; Clark C; Spector DH
Virology; 1994 Dec; 205(2):417-29. PubMed ID: 7975245
[TBL] [Abstract][Full Text] [Related]
13. Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence.
Reading PC; Khanna A; Smith GL
Virology; 2002 Jan; 292(2):285-98. PubMed ID: 11878931
[TBL] [Abstract][Full Text] [Related]
14. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
15. Pathogenicity and immunogenicity in mice of vaccinia viruses mutated in the viral envelope proteins A33R and B5R.
Gurt I; Abdalrhman I; Katz E
Antiviral Res; 2006 Mar; 69(3):158-64. PubMed ID: 16406098
[TBL] [Abstract][Full Text] [Related]
16. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene.
Yuwen H; Cox JH; Yewdell JW; Bennink JR; Moss B
Virology; 1993 Aug; 195(2):732-44. PubMed ID: 8337842
[TBL] [Abstract][Full Text] [Related]
17. A novel Epstein-Barr virus glycoprotein gp150 expressed from the BDLF3 open reading frame.
Kurilla MG; Heineman T; Davenport LC; Kieff E; Hutt-Fletcher LM
Virology; 1995 May; 209(1):108-21. PubMed ID: 7747461
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of B5R mutants of rabbitpox virus in vivo is related to impaired growth and not an enhanced host inflammatory response.
Stern RJ; Thompson JP; Moyer RW
Virology; 1997 Jun; 233(1):118-29. PubMed ID: 9201221
[TBL] [Abstract][Full Text] [Related]
19. The product of a 1.9-kb mRNA which overlaps the HSV-1 alkaline nuclease gene (UL12) cannot relieve the growth defects of a null mutant.
Martinez R; Shao L; Bronstein JC; Weber PC; Weller SK
Virology; 1996 Jan; 215(2):152-64. PubMed ID: 8560762
[TBL] [Abstract][Full Text] [Related]
20. Characterization of vaccinia surface antigen expressed by recombinant baculovirus.
Morikawa S; Ueda Y
Virology; 1993 Apr; 193(2):753-61. PubMed ID: 8460484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]